Table 1.
Time (min) | Procedure |
---|---|
−90 | Confirmation of abstinence from caffeine, alcohol, drugs, medications |
Vital signs | |
Urine drug screen, urine pregnancy test | |
Placement of intravenous lines | |
−60 | Behavioral assessments: PANSS CADSS VAS for “high,” “calm and relaxed,” and “anxiety” |
Blood sampling: Δ-9-THC and THC-COOH | |
Vital signs | |
0 | IV Δ-9-THC (0, 2.5, or 5 mg) over 2 min |
+10 | Vital signs: every 2 min (10 min) followed by every 5 min (20 min) and then every 10 min |
Behavioral assessments: PANSS CADSS VAS for “high,” “calm and relaxed,” and “anxiety” |
|
Blood sampling: Δ-9-THC and THC-COOH | |
+30 | Learning (immediate recall): HVLT |
+45 | Distractibility and vigilance: Gordon Box |
+60 | Delayed Free, cued, and recognition recall: HVLT |
+80 | Behavioral assessments: PANSS CADSS VAS for “high,” “calm and relaxed,” and “anxiety” |
Blood sampling: Δ-9-THC and THC-COOH | |
+140 | Blood sampling: Δ-9-THC and THC-COOH |
+200 | Behavioral assessments: PANSS CADSS VAS for “high,” “calm and relaxed,” and “anxiety” |
Blood sampling: Δ-9-THC and THC-COOH | |
End of each day |
Field sobriety test, Mini-Mental State Examination, vital signs, physician evaluation |
Last day | Exit interview |
Months 1, 3, 6 | Assessment of cannabis use, desire, craving |
Assessment for emergence of new psychiatric or medical problems |
PANSS: Positive and Negative Syndrome Scale; CADSS: Clinician-Administered Dissociative Symptoms Scale; VAS: Visual Analog Scale; Δ-9-THC: Δ-9-tetrahydrocannibinol; THC-COOH: 11-nor-Δ-9-THC-9-COOH; HVLT: Hopkins Verbal Learning Test.